Jiao, Zonglin
Feng, Xiao
Cui, Yuqing
Wang, Lei
Gan, Junqing
Zhao, Yanbin
Meng, Qingwei
Funding for this research was provided by:
National Natural Science Foundation of China (81672931)
Haiyan Foundation of Harbin Medical University Cancer Hospital (JJZD2021-04)
Article History
Received: 26 March 2022
Accepted: 25 July 2022
First Online: 10 August 2022
Declarations
:
: The lung cancer tissues were obtained through pneumonectomy at Harbin Medical University Cancer Hospital. The Ethics Committee of Harbin Medical University Cancer Hospital approved the study. All patients signed informed consent for second use of pathological data and biological specimens. All experimental procedures followed the experimental management regulations of the State Council of the People’s Republic of China, relevant Chinese laws, and the Declaration of Helsinki. All methods in our study were carried out in accordance with relevant guidelines and regulations including institutional guidelines of Harbin Medical University.
: All authors agreed to publish this study.
: All authors declared no potential conflicts of interest.